We are very pleased to welcome our new postdoc, Greg Sliwoski, to the group. Greg received his PhD in Biochemistry from the University of Leipzig in Germany. His research goals include improving rare variant analysis with structural modeling and applying these methods to personalized medicine and drug discovery. His previous research focused on computer-aided drug discovery, GPCR structure prediction and ligand docking, and QSAR descriptor development.